By 
Latvia’s biomedical and photonics innovation platform BioPhoT will present nearly 40 research prototypes at a conference in Riga on October 29, giving researchers and potential partners a public look at technologies now being developed across several of the country’s scientific institutions.
The event, announced on October 28, will take place at the University of Latvia’s House of Science. It is designed as a meeting point for research teams, technology companies, investors, industry representatives and public-sector decision-makers. The working language will be English, and registration remains open through the platform’s website.
From research project to usable technology
BioPhoT focuses on the difficult middle stage between a scientific result and a product or service that can be tested, adopted or commercialised. Its support includes technology development, advice on commercialisation strategy, intellectual-property questions and the search for potential industrial partners.
That focus will shape the conference programme. Two panel discussions will examine how research teams can move technologies from the laboratory towards the market, including the practical obstacles that can slow down development after the research phase has produced a promising result.
The event will also include short presentations from all 66 research teams supported by the platform. Their work covers biomedicine and pharmaceuticals, medical technologies, photonics, smart materials and engineering. The exhibition will allow visitors to see prototypes and hear about their possible applications and further development.
A national platform with a long-term horizon
According to information published by Latvia’s Investment and Development Agency, 66 innovation projects have been developed through BioPhoT since 2025, with €12.7 million invested in their development so far. The platform’s stated objective is to help bring technologies to the commercialisation stage by 2032.
The initiative is being implemented by a network that includes the Institute of Electronics and Computer Science, the University of Latvia, the University of Latvia’s Institute of Solid State Physics, the Latvian State Institute of Wood Chemistry, the Institute of Food Safety, Animal Health and Environment BIOR, Rīga Stradiņš University and Riga Technical University.
The wider BioPhoT project is part of Latvia’s state research programme, “Innovation Fund – Long-term Research Programme”, financed by the Ministry of Economics. The University of Latvia’s Institute of Solid State Physics lists the project’s implementation period as running from December 2024 to November 2026, while the platform itself is intended to support research and innovation activity over a longer period.
Building connections around Latvian science
The conference is not limited to displaying finished objects. Its organisers describe it as an opportunity to discuss how scientific excellence can be translated into globally competitive innovation and how cooperation between science and industry can be strengthened in Latvia.
Participants in one panel will discuss cooperation between researchers and businesses, while another will focus on the route from laboratory work to the market. Speakers listed by the organisers include representatives of the University of Latvia, Riga Technical University, Rīga Stradiņš University, Latvian industry, the Ministry of Economics and private innovation organisations.
This format reflects a practical challenge shared by many research systems: a strong scientific idea does not automatically become a useful technology. Teams may need additional engineering, testing, intellectual-property work, investment and an industrial partner before a prototype can become a product. By putting those groups in the same room, BioPhoT is attempting to make that transition more systematic.
Why the event matters
For Latvia, the conference offers a compact view of the country’s developing strengths in fields that combine scientific research with commercial and societal applications. Photonics and smart materials can support advanced manufacturing and digital technologies, while biomedical and medical research may contribute to diagnostics, treatment and health-related services.
The immediate news is therefore the public presentation on October 29. The longer-term significance will depend on whether the contacts made at the conference lead to testing, investment, new partnerships or products. For now, BioPhoT is offering a visible snapshot of Latvian research teams working to close the gap between an idea in a laboratory and a technology that can be used outside it.
Comments